Acorda’s closure date is set for 15 June, as Merz Therapeutics looks set to acquire the biotech’s once-prolific assets.

Shrimp acorda may be the best Portuguese food that you've not yet eaten. In this dish, flavors of the sea combine with ...

Acorda Therapeutics said it filed for bankruptcy protection and secured a “stalking horse” bid for its assets ahead of an auction process. The Pearl River, N.Y.-based pharmaceutical company ...

Shares of Acorda Therapeutics ACOR fell late Monday after the company said it had filed for bankruptcy protection. The stock was down 38%, to $8.40, in late trading, following a 2% rise at Monday ...

Acorda Therapeutics shares are trading lower by 87% during Tuesday's session. The company on Monday provided a series of business updates. Loading... Loading ...

Acorda Therapeutics develops therapies to restore function and improve the lives of people with neurological disorders.

Acorda Therapeutics has filed for bankruptcy and, on Monday, announced it has reached an agreement to sell essentially all its assets to another drugmaker. Acorda said it chose to pursue Chapter ...

Acorda Therapeutics has filed for bankruptcy protection, hoping to keep operating while it tries to arrange the sale of its main assets to a US subsidiary of Germany’s Merz. The announcement ...

PEARL RIVER, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will no longer hold its fourth quarter and year end 2023 earnings conference call originally ...

This press release includes forward-looking statements. All statements, other than statements of historical facts, regarding management's expectations, beliefs, goals, plans or prospects should be ...